In line with the idea that cancer cells require increased transcriptional elongation for their high turn-over metabolism, CDK9 has been shown to be dysregulated in several cancers [49–51] to favor cancer cell proliferation, apoptosis resistance and spread. This evidence concerns the gene CDK9 and cancer.